STOCK TITAN

ALEC insider RSU vesting and proposed 23,019-share sale on Nasdaq

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Alector, Inc. (ALEC) Form 144 notice shows that 23,019 shares of Common Stock (aggregate market value $54,094.65) are proposed to be sold through Morgan Stanley Smith Barney on 09/02/2025 on Nasdaq. The shares were acquired on 08/29/2025 by vesting of restricted stock units from the issuer, with 45,330 RSU units recorded as acquired that date. The filing also discloses a prior sale by the same person: 23,890 shares sold on 06/02/2025 for $31,974.38. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Positive

  • Clear compliance with Rule 144 procedures by identifying broker, sale date, and share quantities
  • Disclosure of acquisition details showing shares were acquired via vesting of RSUs on 08/29/2025
  • Prior recent sale disclosed (23,890 shares sold on 06/02/2025 for $31,974.38), improving transparency

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice for vested RSUs and a small proposed market sale; immaterial to capitalization.

The filing documents a proposed sale of 23,019 shares valued at $54,094.65 and discloses a recent sale of 23,890 shares for $31,974.38. The securities were acquired by vesting of restricted stock units on 08/29/2025. Given the issuer's reported outstanding shares of 101,212,329, the proposed sale represents a de minimis portion of the float and is unlikely to move market valuation. The use of a broker (Morgan Stanley Smith Barney) and the Rule 144 framework indicate the seller is following standard resale procedures.

TL;DR: Disclosure aligns with compliance expectations; provides transparency on insider vesting and resale activity.

The form identifies the nature of acquisition as vesting of RSUs and specifies acquisition and payment dates (08/29/2025). It also contains the seller's signed representation about absence of undisclosed material adverse information and references potential trading-plan disclosures. This level of detail meets typical governance and disclosure standards for officer/director/affiliate transfers under Rule 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Alector (ALEC) disclose about the proposed sale?

The form discloses a proposed sale of 23,019 shares of Common Stock through Morgan Stanley Smith Barney on 09/02/2025 with an aggregate market value of $54,094.65.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/29/2025 by the vesting of restricted stock units from the issuer; 45,330 units are listed as acquired.

Did the filer disclose any recent sales of the issuer's stock?

Yes. The filing shows Sara Kenkare-Mitra sold 23,890 shares on 06/02/2025 for $31,974.38.

On which exchange and through which broker is the proposed sale to occur?

The proposed sale is to occur on Nasdaq through Morgan Stanley Smith Barney LLC Executive Services.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. By signing the notice the seller represents they do not know any material adverse information
Alector

NASDAQ:ALEC

ALEC Rankings

ALEC Latest News

ALEC Latest SEC Filings

ALEC Stock Data

210.66M
98.25M
10.37%
77.1%
5.36%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO